Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.37 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | JAK1 | P23458 | 3/20 | 0.32 |
| ▸ | JAK3 | P52333 | 3/20 | 0.32 |
| ▸ | JAK2 | O60674 | 2/20 | 0.32 |
| ▸ | TYK2 | P29597 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7561771 | 0.87 | CYP1A2 (0.36) | CYP1A2CYP2D6CYP3A4CYP2C19SLC29A1 | |
| SCHEMBL16146619 | 0.82 | SLC29A1 (0.40) | CYP1A2CYP2D6SLC29A1UTS2RCDK2 | |
| SCHEMBL16146189 | 0.81 | CYP1A2 (0.42) | CYP1A2SLC29A1UTS2RCDK2ALDH1A1 | |
| SCHEMBL21788563 | 0.81 | SLC29A1 (0.39) | CYP1A2CYP2D6SLC29A1UTS2RALDH1A1 | |
| SCHEMBL16145765 | 0.81 | SLC29A1 (0.42) | CYP1A2CYP2D6SLC29A1UTS2RALDH1A1 | |
| SCHEMBL20118 | 0.80 | CYP1A2 (0.70) | CYP1A2CYP2D6CYP3A4CYP2C19CDK2 | |
| SCHEMBL29392628 | 0.80 | CYP1A2 (0.70) | CYP1A2CYP2D6CYP3A4CYP2C19CDK2 | |
| SCHEMBL3241687 | 0.80 | PPARG (0.34) | CYP1A2CYP2D6CYP3A4CYP2C19CCNE1 | |
| SCHEMBL17372396 | 0.76 | LMNA (0.42) | CYP1A2CYP2D6CYP3A4CYP2C19KDM4E | |
| SCHEMBL11831291 | 0.76 | CXCR2 (0.38) | CYP1A2CYP2D6CYP3A4CYP2C19UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2694524-B1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | US HEALTH (US) | 2016-05-18 | — | — | EP | claimed |
| US-9284343-B2 | 2′-O-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2016-03-15 | — | — | US | claimed |
| EP-2567964-B1 | Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection | AGILENT TECHNOLOGIES INC (US) | 2015-02-11 | — | — | EP | claimed |
| US-20140051846-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | TheUnited ofAmerica,asrepresentedbythe Secre -tary,Department ofHealthand Human Service (US) | 2014-02-20 | — | — | US | claimed |
| EP-2694524-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2014-02-12 | — | — | EP | claimed |
| WO-2012138530-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-10-11 | — | — | WO | claimed |
| US-7807356-B2 | Labeled nucleotide composition | AGILENT TECHNOLOGIES, INC. (US) | 2010-10-05 | — | — | US | claimed |
| US-7524942-B2 | Labeled nucleotide composition | AGILENT TECHNOLOGIES, INC. (US) | 2009-04-28 | — | — | US | claimed |
| US-20080124708-A1 | Labeled nucleotide composition | AGILENT TECHNOLOGIES, INC. | 2008-05-29 | — | — | US | claimed |
| US-20070212697-A1 | Labeled nucleotide composition | AGILENT TECHNOLOGIES, INC. | 2007-09-13 | — | — | US | claimed |
| EP-4748940-A2 | DE NOVO SYNTHESISED GENE LIBRARIES | Twist Bioscience Corporation (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | disclosed |
| US-20260138111-A1 | DE NOVO SYNTHESIZED GENE LIBRARIES | Twist Bioscience Corporation (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4743580-A1 | EFFICIENT TRANSGENE-FREE GENOME EDITING IN PLANTS IN THE T0 GENERATION BASED ON A CO-EDITING STRATEGY | University of Florida Research Foundation, Incorporated (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3790985-B1 | METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTACTIVATED AGENTS | VIBRANT HOLDINGS LLC (US) | 2026-04-15 | — | — | EP | disclosed |
| US-6222030-B1 | CONDENSING HYDROXY GROUP OF BOUND OLIGONUCLEOTIDE OR NUCLEOSIDE WITH NUCLEOSIDE PHOSPHORAMIDITE HAVING CARBONATE-PROTECTED HYDROXYL GROUP, TREATING WITH DEPROTECTING AGENT ALSO OXIDIZES PHOSPHITE TRIESTER LINKAGE | AGILENT TECHNOLOGIES, INC. | 2001-04-24 | — | — | US | disclosed |
| WO-2001014401-A1 | NUCLEOSIDE PYROPHOSPHATE AND TRIPHOSPHATE ANALOGS AND RELATED COMPOUNDS AS THERAPEUTIC AGENTS | SRI INTERNATIONAL (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2000012524-A1 | PURIFICATION OF OLIGOMERS USING DUAL-END SELECTION | BAYER CORPORATION (US) | 2000-03-09 | — | — | WO | disclosed |
| EP-0984021-A2 | Synthesis of oligonucleotides | Hewlett-Packard Company (US) | 2000-03-08 | — | — | EP | disclosed |
| EP-0147689-B1 | A METHOD OF INDUCING ANTITUMOR IMMUNOCYTES, AND A PROCESS FOR PRODUCING ANTITUMOR IMMUNOCYTES AND ANTITUMOR IMMUNOCYTES PRODUCED BY THE PROCESS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1990-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080124708-A1 | Labeled nucleotide composition | RNGTT, RNMT, NOP2 | CYP1A2 3227/4885CYP2D6 2787/4885CYP3A4 3828/4885 |
| US-20070212697-A1 | Labeled nucleotide composition | RNGTT, RNMT, NOP2 | CYP1A2 3227/4885CYP2D6 2787/4885CYP3A4 3828/4885 |
| US-20260138111-A1 | DE NOVO SYNTHESIZED GENE LIBRARIES | POLM, DNMT3A, POLN | CYP1A2 2361/4885CYP2D6 1210/4885CYP3A4 2960/4885 |
| US-20140051846-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | NSUN2, RNGTT, RNMT | CYP1A2 3150/4885CYP2D6 2529/4885CYP3A4 3895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.